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ANALYSIS OF DISEASE BEHAVIOR OF PATIENTS WITH HEMATOPOIETIC
STEM CELL TRANSPLANTATION AND NURSING CARE
Su, R., Tang, Y.J. 301 Hospital, Beijing, China
Purpose To analysis the ill behavior of patients with hematopoi-
etic stem cell transplantation. Methods The questionmaire of ill
behavior was adopted and 17 patients with hematopoietic stem cell
transplantation were asked to answer the questions. Results Faith
in disease and belief in disease were both lower than normal
standards. The index of double in disease fell in the normal, but
their psychological orientation was higher. They were mentally
healthy like a non-disease person but carried special psychologic
behavior as patients with hematopoietic stem cell transplantation.
Conclusions It is necessary to education patients with hematopoi-
etic stem cell transplantation.
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STEM CELL TRANSPLANTATION FOR METACHROMATIC LEUKODYS-
TROPHY: A FAMILY CENTERED APPROACH
Maurice, L.C. Sydney Children’s Hospital, Sydney, NSW, Australia
At Sydney Children’s Hospital, Stem cell transplant is offered as
a potential cure to children who suffer from certain malignant and
non-malignant diseases. When a family is confronted with the
same life threatening illness in two siblings, the devastation and
emotions are tremendous. As their 2-year-old daughter is diag-
nosed with Metachromatic leukodystrophy (MLD) the future of
the unborn sibling remains unclear. As the family is told that
curative treatment can only be offered to one sibling, they must
simultaneously prepare for the inevitable death of the other.
This presentation will discuss the management of an infant un-
dergoing a stem cell transplant at the age of 6 weeks, whilst his
sister is receiving palliative care for the same disease. Metachro-
matic leukodystrophy is an autosomal recessive lysosomal storage
disorder occurring in 1: 40 000 births. It is characterised by the
accumulation of lipid (sulfatide) primarily in the central nervous
system resulting in progressive neurodegenerative function. MLD
is caused by the deﬁciency of the enzyme arylsulfatase which is
responsible for the breakdown of sulfatide.
During the last decade, stem cell transplantation has been used
successfully to correct several genetic metabolic disorders by re-
placing cells of haematopoietic origin that can restore the deﬁcient
enzymes in the recipient. The most common variety of MLD
appears in early childhood, but the disease may also occur in adults.
It usually leads to progressive paralysis and, in children, early death
occurs.
The advances in diagnostic medicine made it possible to diagnose
the newborn within weeks of life, offering the family some hope of
cure. This presentation will discuss the approach the health care
team took in looking after a transplant family who are on such a
huge roller coaster ride, and it will describe how this family was
managed on the transplant unit.
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TO BLEED OR NOT TO BLEED? THAT IS THE QUESTION (NURSING
MANAGEMENT OF PATIENT WITH HEMORRHAGIC CYSTITIS POST BMT)
Dela Cruz, B.P. MD Anderson Cancer Center, Houston, TX
Hemorrhagic cystitis is a syndrome of hematuria with symptoms
of urinary tract irritability indicated by dysuria, frequency and
urgency. Incidence varies according to conditioning regimen, pre-
ventative measures employed, and graft versus host disease pro-
phylaxis used. There are two types of occurrences: 1. Early onset
happens during or shortly after the conditioning regimen in which
patients may have received cyclophosphamide, ifosphamide or
busulfan. 2. Late onset occurs weeks to months after bone marrow
transplant related to contraction of certain viruses.
BMT patient who are immunocompromised, viruses are reacti-
vated and excreted in the urine. In general viral shredding occurs
2-8 weeks after BMT and resolves spontaneously within three
weeks. Another risk factor that contributes to hemorrhagic cystitis
is GVHD. The bladder epithelium is a target organ for GVHD to
attack and immunosuppressed patients already having associated
complications with GVHD have an increased risk for acquiring
viral infections.
Standard treatment modalities of hemorrhagic cystitis are: 1.
Hydrating patients with intravenous and oral ﬂuids. 2. Continuous
bladder irrigation. 3. Bladder Instillation with Alum, Carboprost,
silver nitrate, phenol, prostaglandin, and hydrocortisone. 4. Giving
smooth muscle relaxants for bladder spasms. 5. Antiviral therapy. 6.
Cystoscopy. 7. Our center is studying NOVO-seven injections to
help with the clotting mechanism.
The nurses have an essential role in early detection. Mnemonics
that would assist nurses in patient assessment is “U PAAS BI.”
U-urinary output, P-pain management, A–assessment of urine,
S–specimen collection for urine cytology, B–blood counts and
I-infusion of blood products as necessary.
Chemotherapy and viruses may account for a substantial propor-
tion of late onset and long lasting hemorrhagic cystitis in BMT
patients. In conclusion, nursing plays a huge role in prevention,
early detection and treatment of hemorrhagic cystitis.
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THE DEVELOPMENT OF A NEED ASSESSMENT TOOL FOR FAMILIES OF
BMT PATIENTS
Lee, Y.-S.1, Tak, Y.-R.2, Yun, E.-W.2, Lee, K.-H.1, Lee, J.-H.1, Choi,
S.-J.1, Seol, M.1, Lee, J.-S.1 1. Asan Medical Center, Seoul, Korea;
2. Hanyang University, Seoul, Korea
BMT is now mostly used to treat patients with advanced malig-
nancies. However, health care provider’s attention is prioritized
toward BMT patients for the BMT trajectory, although uncer-
tainty of survival, high cost, many physical changes of patient cause
signiﬁcant distress, anxiety, and burden on family. Preliminary
study ﬁndings suggested that needs of family of patient were
consisted with the needs for information, assurance, convenience,
proximity, and support. Therefore, this research was designed to
develop the need assessment tool that can be used for identifying
and assessing what are needs of family of BMT patients. The data
for the tool were collected from in-depth interview with family of
BMT patients, self-reports of health care provider, and literature
review. From the content analysis, the needs were identiﬁed as 61
items. In order to test reliability and factor analysis, 120 family
members of BMT patients were sampled from September 2001 to
July 2003 in Korea.
Results from factor analysis, 9 factors were conﬁrmed. Factor
1(Need for information of treatment procedure and patient’s
health status), Factor 2(Need for patient’s comfort), Factor 3(Need
for social support), Factor 4(Need for emotional support), Factor
5(Need for follow up care), Factor 6(Need for family’s conve-
nience), Factor 7(Need for self assurance), Factor 8(Need for
reliable relationship with medical staffs), and Factor 9(Need for
physical environment of BMT unit).
As results, the need assessment tool showed high reliability
(Chronbach’s alpha was .93) and exploring nine factors of needs for
the family with BMT patient. The assessed need of family of BMT
patients will guide health care providers for the family intervention
program, and to serve the effective and evidence based care for the
family with BMT patients.
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A SUPPORT NETWORK FOR PATIENTS AND FAMILIES AFTER BLOOD
AND MARROW TRANSPLANTATION
Anders, V.L. Johns Hopkins University, Baltimore, MD
Patients who are treated with blood and marrow transplantation
(BMT) may feel alone and isolated as they recover from this
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intense treatment. These feelings are compounded when they
develop complications such as chronic graft-versus-host disease
(cGVHD). The Plunge for Patients, which was originally started as
a fund raising event, has now become a support network for
patients and families after BMT. The weekend event includes
beach runs, ocean swims, and a patient and family beach party.
Patients and families who attend the Plunge for Patients are able to
meet others who share similar experiences, treatments, and com-
plications. Caregivers and family members are able to share hints
and gain support. Families who have lost a family member also
attend the event, often gaining closure, and later are able to
celebrate the life of their loved one by sharing pictures and their
life stories. Many patients and family members meet throughout
the year to help plan for the event and assist with fund raising.
Most patients and/or families write a short story about their expe-
riences and share it the athletes. The patients, families, and athletes
meet each other after the races. Many teenagers who have attended
the races have chosen careers in the health care ﬁeld after meeting
the patients and families and reading their inspirational stories.
The Plunge for Patients is open to all patients who have received
a transplant at any center around the world. This is particularly
valuable to patients with cGVHD, where the physical manifesta-
tions of the disease are distressing to the patient. Because of the
large number of patients with chronic GVHD attending the event,
many patients are able to ﬁnd “buddies” who are a similar age and
sex to help them deal with the ongoing struggles of this debilitating
illness.
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BE IMPRESSED WITH PRES
Mishaw, K., de Lima, M., Giralt, S., Hosing, C. University of TX MD
Anderson Cancer Center, Houston, TX
Posterior reversible encephalopathy syndrome (PRES) has re-
cently been described post allogeneic hematopoietic stem cell
transplant in patients receiving Tacrolimus.
The neurotoxocity associated with calcineurin inhibitors such as
Tacrolimus are usually limited to mild symptoms such as headache,
tremors, parethesias, insomnia, photophobia and mood distur-
bances. A more severe neurotoxocity has been seen in selected
patients and includes altered mental status, cognitive deﬁcits, sei-
zures, visual disturbances and coma. This clinical picture along
with distinct radiologic ﬁndings of edema involving the white
matter in the posterior portions of the cerebral hemispheres re-
sulted in the terminology, posterior reversible encephalopathy syn-
drome.
PRES is associated with various etiologies, one of which is use of
immunosuppression such as Tacrolimus and Cyclosporin. The
pathophysiology with immunosuppressive agents is not well delin-
eated but is thought to be due to an acute episode of vasogenic
edema in the vertebral white matter with a predeliction for the
posterior temporal, parietal and occipital regions. The extracellular
edema is attributed to autoregulatory dysfunction in the posterior
circulation and with a transient breakdown of the blood brain
barrier with a leakage of protein/ﬂuids causing the neuronal injury.
Since PRES is progressive but potentially reversible, early detec-
tion and intervention is paramount. Nurses need to be aware of this
rare syndrome and knowledgeable of signs/symptoms of the sub-
acute prodromal period. Early identiﬁcation of these s/s would
provide the medical team an opportunity to initiate treatment early
thereby minimizing morbidity. Nurses also need to be knowledge-
able of the medical treatment and nursing management required by
patients experiencing this syndrome.
This presentation will utilize 3 case scenarios to review the
clinical presentation, pathophysiology, known risk factors, differ-
ential diagnosis, diagnostic imaging, medical treatment and nurs-
ing management of patients experiencing PRES.
261
WE ARE KINDER TO OUR PATIENTS THAN WE ARE TO EACH OTHER:
HOW CAN WE ACT THE SAME TOWARD EVERYONE?
Sorensen, S.H., Tran, H.T., Canales, L., Valdez, M., Holmes, T. M D
Anderson Cancer Center, Houston, TX
We were recently asked to participate in an Institutional wide
Employee Opinion Survey (EOS). One of the most interesting
ﬁndings was that approximately 60 % of the employees in our
institution thought we were kinder to our patients than we were to
each other. We were challenged to improve this rating.
The Apheresis group picked an EOS team to lead this challenge.
The members surveyed the group to ﬁnd the 2 areas they wanted
to improve the most. Based on the outcomes of this survey, aim
statements were developed.
The ﬁrst identiﬁed questioned our behaviors and actions toward
our co-workers regarding consistency with our Core Values of
“Caring-by our words and actions, we create a caring environment
for everyone.” The second questioned whether employees at the
institution are able to contribute to their fullest potential regardless
of their age, race, ethnic background, gender, religion or disability
statue.
To meet the above stated objectives, the plan was to develop a
“voice box” for the employees to share their thoughts on the
following: What went well this week?, What didn’t go well?, and
suggestions for improvement.
The EOS team gathers these responses and lists them for the
team to talk about at a lunch meeting every other week.
Thus far, we have discussed the following with positive results:
Need for “report” when taking over procedures for lunch or at the
end of the day, “Ofﬁcially” agreed upon times for lunch, Stocking
each area daily, Completing documentation, Run times for proce-
dures and Standard Operating Procedures (SOP) development.
The staff have been encouraged by these discussions. They have
commented on how potentially explosive issues have been resolved
as a group with each member respecting the others opinion while
maintaining a democratic approach.
The above results were presented to the Chief Operating Ofﬁc-
ers of the Institution to rave reviews. The next step is to incorpo-
rate the best ideas from each unit and apply them at an institutional
level.
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IMPROVING CLINICAL AND OPERATIONAL OUTCOMES THROUGH A
SHARED GOVERNANCE PRACTICE COUNCIL STRUCTURE
Johnston, P., Blackburn, R., Causton, C., Davis, L., Dela Cruz, B.,
Jewell, J. UT MD Anderson Cancer Center, Houston, TX
Nursing in today’s ever-changing, complex healthcare environ-
ment encounters multiple challenges, including: role expansion,
cost-containment efforts, and the healthcare system’s redesign to
prepare for forecasted issues facing the profession. While these
challenges can be overwhelming, nurses no longer accept the
assignment of tasks as their practice goal outcomes. Today’s nurses
seek opportunities to provide comprehensive professional care
through a system that supports autonomy and staff input regarding
decision-making. Traditional models of administrative structures
are presently in a state of ﬂux as organizational structures ﬂatten
and team structures increase. Creating environments of teamwork
and creativity are essential for achieving desired improvement in
clinical and operational outcomes. Building upon the nursing di-
vision’s shared governance practice council structure, the inpatient
BMT unit replicated the majority of practice councils at the unit
level. These included a: Clinical Practice Council, Research Coun-
cil, Education Council, Quality Improvement Council, and Coor-
dinating Council. Annually each council is responsible for estab-
lishing goals. Active participation is expected by the nursing staff in
achievement of a component of their professional development
model evaluation. Improved outcomes achieved this past year in-
cluded: preparation for the Foundation for the Accreditation of
Cellular Therapy (FACT) survey, development of BMT nursing
standards of care formatted to meet FACT accreditation guide-
lines, a BMT patient education manual, monitoring nursing doc-
umentation audits, redesigning the measurement of patient satis-
faction with nursing care, developing and instituting this year’s
unit based competencies, and a staff recognition program. The
outcomes of shared decision making have promoted effective qual-
ity patient care, accountability, staff and leadership satisfaction and
professional role development demonstrating the mission, vision,
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